Canakinumab treatment in patients with colchicine-resistant familial mediterranean fever: a multicenter observational study
Canakinumab demonstrates excellent efficacy and favorable safety as a treatment for cr-FMF. Our study is the first to indicate the efficacy of CAN in reducing serum creatinine levels.
Authors
- Mete Kara
- Mete Pekdiker (ORCID: https://orcid.org/0000-0003-3089-1564)
- EMRAH KOÇ
Institutions
- Izmir Bozyaka Eğitim ve Araştırma Hastanesi (TR)
- Mustafa Kemal University (TR)
Publication Details
- Journal
- TURKISH JOURNAL OF MEDICAL SCIENCES
- Published
- 2026-02-12
- DOI
- https://doi.org/10.55730/1300-0144.6133
- Primary Topic
- Inflammasome and immune disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00